The Management and Treatment of Parkinson's Disease
 

A continuing medical education activity sponsored by NAMCP and AAMCN
This activity is an archive of live webinars held March 2009

This activity is valid from June 25, 2009 to February 15, 2010

 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from Teva Neuroscience

PLEASE CLICK HERE TO VIEW PRESENTATION


PLEASE CLICK HERE FOR POST TEST AND EVALUATION

PLEASE CLICK HERE TO VIEW VIDEO FILES

Instructions for CME/CEU:  View the presentation, answer the post test, complete the evaluation form and submit to keads@namcp.org A score of 70% must be achieved on the post test to receive continuing education credits. You will have the option on the post test/evaluation page to submit your forms electronically or by faxing them to Katie Eads at 804-747-5316.

Description
Research suggests that Parkinson's Disease (PD) affects at least 500,000 people in the United States, and some estimates are much higher. The total cost to the nation is estimated to exceed $6 billion annually. The financial and public health impact of this disease is expected to increase as the population ages.

Objectives
  • Review the American Academy of Neurology's Treatment Guidelines for Parkinson's disease

  • Compare and contrast the efficacy and safety of dopamine agonists, levodopa and monamine oxidase inhibitors Describe current neuroprotection strategies and recent trials

  • Describe the impact of combination therapies on patients' "OFF" (immobile) time

  • Recognize what patients are candidates for surgical management of advanced PD
     

Faculty: Leo Verhagen, M.D., Ph.D.
Associate Professor of Neurological Sciences
Rush University Medical Center

Disclosure:

Dr. Verhagen has disclosed the following relationships:
Consultant: Medtronic
Speaker: Ipsen
  The NAMCP planning committee has no real or perceived financial relationships to disclose.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. NAMCP designates this activity for a maximum of 1.5 AMA PRA Category I creditsTM. Each physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses (AAMCN) has been approved as a provider of continuing education by the Virginia Nurses Association (VNA).  VNA is accredited as an approver of continuing education in nursing by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses who complete this activity will be awarded 1.8 contact hours.

This activity has been approved by the American Board of Managed Care Nursing for 1.8 contact hours toward CMCN recertification requirements.
.

  

This activity is supported by an educational grant from Teva Neuroscience